Information Provided By: 
Fly News Breaks for February 11, 2020
FLDM
Feb 11, 2020 | 05:12 EDT
Piper Sandler analyst William Quirk lowered his price target for Fluidigm to $9 from $14 following the company's Q4 results and keeps an Overweight rating on the shares. Management is ramping up sales hires to support new products and the ongoing Mass Cytometry business, a change from its historical approach and a positive sign, Quirk tells investors in a research note. He says his new price target better reflects Fluidigm's current growth rate.
News For FLDM From the Last 2 Days
There are no results for your query FLDM
